Cargando…
Modulation of Leukocytes of the Innate Arm of the Immune System as a Potential Approach to Prevent the Onset and Progression of Type 1 Diabetes
Type 1 diabetes (T1D) is characterized by insulin deficiency resulting from the selective destruction of pancreatic β-cells by self-reactive T cells. Recent evidence demonstrates that innate immune responses substantially contribute to the pathogenesis of T1D, as they represent a first line of respo...
Autores principales: | Petrelli, Alessandra, Atkinson, Mark A., Pietropaolo, Massimo, Giannoukakis, Nick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881863/ https://www.ncbi.nlm.nih.gov/pubmed/33472941 http://dx.doi.org/10.2337/dbi20-0026 |
Ejemplares similares
-
It’s Time to Bring Dendritic Cell Therapy to Type 1 Diabetes
por: Creusot, Rémi J., et al.
Publicado: (2014) -
Primer: Immunity and Autoimmunity
por: Pietropaolo, Massimo, et al.
Publicado: (2008) -
Immune Recognition of β-Cells: Neoepitopes as Key Players in the Loss of Tolerance
por: James, Eddie A., et al.
Publicado: (2018) -
Recent Lessons Learned From Prevention and Recent-Onset Type 1 Diabetes Immunotherapy Trials
por: Staeva, Teodora P., et al.
Publicado: (2013) -
Autoimmune Inflammation and Insulin Resistance: Hallmarks So Far and Yet So Close to Explain Diabetes Endotypes
por: Petrelli, Alessandra, et al.
Publicado: (2021)